About the study
Despite the growing number of medicinal cannabis products being prescribed, there remains a significant scientific evidence gap relating to the safety, effectiveness, routes of administration and formulations of medicinal cannabis products. As a result, doctors need to rely on limited evidence to justify and guide the clinical use of medicinal cannabis.
To help address this evidence gap, the Victorian Office of Medicinal Cannabis is leading a national study of medicinal cannabis use in Australia. Patients that have been legally prescribed medicinal cannabis and their prescribing medical practitioner have been asked to participate in online voluntary surveys, providing information about their experience with medicinal cannabis.
This surveys collect information focusing on the patterns of use, effectiveness and safety of medicinal cannabis products prescribed in Australia. The results of this study will be made available to researchers for further analysis, and provide much needed information to guide policy decisions relating to medicinal cannabis in Australia.
This project has been developed by the Victorian Office of Medicinal Cannabis, Department of Health and Human Services, in partnership with the Independent Medical Advisory Committee for medicinal cannabis (including Chairperson, Professor James Angus, who is also Chair of the Australian Advisory Council on the Medicinal use of Cannabis), and academic partners at the University of Melbourne and the Lambert Initiative for Cannabinoid Therapeutics, University of Sydney.
Ethics approval to begin the study was granted by the Monash Health Human Research Ethics Committee.
The Australian Medicinal Cannabis Study began in late 2018 and will recruit participants over a 3 year period, with final surveys completed 15 months later.
Initial results of the study will be made available in a de-identified, aggregate form and published on this page twice annually.
The final results of the study will be published following the completion of the study and after a further period of time to allow for adequate analysis to take place.
No results available.